SCHEMBL7137693

SCHEMBL7137693

CCOC(=O)CNC(C)C#N

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.45
MGAM O43451 1/20 0.45
SI P14410 1/20 0.45
MGAM2 Q2M2H8 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 4/20 0.38
TRPA1 O75762 1/20 0.38
TSHR P16473 2/20 0.36
NPSR1 Q6W5P4 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PPID Q08752 1/20 0.34
KDM4E B2RXH2 1/20 0.34
POLB P06746 1/20 0.34
GLA P06280 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
ADORA3 P0DMS8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7737356 0.82 GAA (0.42) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL8326561 0.80 GAA (0.43) GAAMGAMSIMGAM2SMN1; SMN2
SCHEMBL452234 0.78 GAA (0.54) GAAMGAMSIMGAM2SMN1; SMN2
SCHEMBL7430700 0.76 GAA (0.52) GAAMGAMSIMGAM2SMN1; SMN2
Hydrochloric Acid SCHEMBL5595600 0.76 GAA (0.52) GAAMGAMSIMGAM2SMN1; SMN2
SCHEMBL8326562 0.75 GAA (0.42) GAAMGAMSIMGAM2SMN1; SMN2
SCHEMBL13774331 0.75 GAA (0.50) GAAMGAMSIMGAM2SMN1; SMN2
SCHEMBL21578650 0.75 GAA (0.50) GAAMGAMSIMGAM2SMN1; SMN2
SCHEMBL7721965 0.75 GAA (0.50) GAAMGAMSIMGAM2SMN1; SMN2
SCHEMBL11193578 0.75 GAA (0.50) GAAMGAMSIMGAM2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506761-B1 Compound of the invention are active as inhibitors of Thrombin and are useful in treating disease states in mammals which are characterized by abnormal thrombosis and have the following structure: CORVAS INTERNATIONAL, INC. 2003-01-14 US disclosed
US-6506760-B1 Compounds of the invention are active as inhibitors of Thrombin and are useful in treating disease states in mammals which are characterized by abnormal thrombosis and have the following structure: CORVAS INTERNATIONAL, INC. 2003-01-14 US disclosed
WO-2001079193-A2 SUBSTITUTED HYDRAZINYL HETEROAROMATIC INHIBITORS OF THROMBIN CORVAS INTERNATIONAL, INC. (US) 2001-10-25 WO disclosed
US-4421693-A INSECTICIDES, MITICIDES OR NEMATOCIDES OTSUKA CHEMICAL CO., LTD. (JP) 1983-12-20 US disclosed
US-4413005-A 2,3-DIHYDRO-2,2-DIMETHYLBENZOFURAN-7-YL DERIVATIVES OTSUKA KAGAKU YAKUHIN KABUSHIKI KAISHA (JP) 1983-11-01 US disclosed